Glycosaminoglycan biosynthesis pathway

The glycosaminoglycan biosynthesis pathway refers to a complex, multi-enzyme biological process by which glycosaminoglycans (GAGs)—long, linear polysaccharides with repeating disaccharide units—are synthesized. These polymers are major structural and functional components of proteoglycans in the extracellular matrix. The pathway includes the activation of nucleotide sugars in the cytoplasm, assembly of a core tetrasaccharide linker on specific serine residues of core proteins, and subsequent elongation and modification (sulfation, epimerization) by glycosyltransferases, sulfotransferases, and epimerases, primarily in the Golgi apparatus. Enzymes in this pathway include peptide O-xylosyltransferases, galactosyltransferases, glucuronyltransferases, and various sulfotransferases. GAG biosynthesis is required for tissue development, cell signaling, and structural integrity. Defects in this pathway are associated with inherited connective tissue diseases and contribute to tumor progression, making pathway components of interest in disease biology but not themselves a direct therapeutic "target" in the sense of a single receptor, enzyme, or transporter[1][2][3][6][8].

Other names

glycosaminoglycan biosynthesisGAG biosynthesisglycosaminoglycan biosynthetic process